Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

718
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
718
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

586
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

556
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

371
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory and Nested Testicular Sex Cord Tumors: Clinical and Molecular Characterization.

Genes·2026
Same author

19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.

Cancer genetics·2026
Same author

MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers.

Immunotherapy·2026
Same author

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol.

Clinical and experimental medicine·2026
Same author

SKP2 at the crossroads of proliferation and immune evasion: a new target in the tumor microenvironment.

Precision clinical medicine·2025
Same author

Cancer vaccines: advances, hurdles, and future directions.

Exploration of targeted anti-tumor therapy·2025
Same journal

Predictive Value of the Pulmonary Artery Pulsatility Index in Pulmonary Arterial Hypertension: REVEAL Analysis.

Cardiology research·2026
Same journal

Comparison of Single-Freezing Temperature-Guided and Conventional Time-to-Isolation-Guided Protocols of Cryoballoon in Atrial Fibrillation Ablation.

Cardiology research·2026
Same journal

Sardjito Cardiovascular Intensive Care Score as an Alternative to Mayo Cardiac Admission Risk Score for Predicting Mortality in Cardiovascular Intensive Care Patients.

Cardiology research·2026
Same journal

Strong Adherence to Cardiac Rehabilitation Program Improves Exercise Tolerance in Outpatients With Cardiovascular Disease.

Cardiology research·2026
Same journal

Association of Circulating Brain-Derived Neurotrophic Factor With Coronary Risk Factors and Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Cardiology research·2026
Same journal

Role of Intracoronary Imaging in Percutaneous Coronary Intervention for In-Stent Restenosis: A Prospective Observational Study.

Cardiology research·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

43.3K

Basic Concepts in Metastatic Cardiac Disease.

Panagiotis J Vlachostergios1, Danai D Daliani1, Christos N Papandreou1

  • 1Department of Medical Oncology, University Hospital of Larissa, University of Thessaly School of Medicine, Biopolis 41110, Larissa, Greece.

Cardiology Research
|March 29, 2017
PubMed
Summary
This summary is machine-generated.

Metastatic cancer involving the heart is rare and often asymptomatic, making diagnosis challenging. This review covers the incidence, location, presentation, diagnosis, and treatment of cardiac tumors in cancer patients.

Keywords:
CancerHeart metastasis

More Related Videos

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

7.0K

Related Experiment Videos

Last Updated: Mar 5, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

43.3K
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

8.9K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

7.0K

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Cardiac metastases are uncommon in clinical practice.
  • Symptoms of heart involvement by cancer are often absent or non-specific.
  • Metastatic heart tumors can be misdiagnosed or attributed to other conditions.

Purpose of the Study:

  • To review the incidence of cardiac metastases.
  • To discuss the clinical presentation and diagnosis of metastatic heart tumors.
  • To outline current treatment strategies for cardiac tumors in cancer patients.

Main Methods:

  • Literature review of studies on metastatic cardiac tumors.
  • Analysis of reported cases regarding incidence and location.
  • Synthesis of diagnostic and therapeutic approaches.

Main Results:

  • Cardiac involvement by cancer is a rare diagnosis.
  • Intracardiac location and clinical presentation vary widely.
  • Diagnosis often relies on advanced imaging and biopsy.
  • Treatment is typically palliative.

Conclusions:

  • Early recognition of cardiac metastases is crucial despite rarity.
  • Multidisciplinary approach is essential for optimal management.
  • Further research is needed to improve outcomes for patients with metastatic heart tumors.